Market revenue in 2023 | USD 320.7 million |
Market revenue in 2030 | USD 894.2 million |
Growth rate | 15.8% (CAGR from 2023 to 2030) |
Largest segment | On-body |
Fastest growing segment | Off-body |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | On-body, Off-body |
Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 54.69% in 2023. Horizon Databook has segmented the Japan wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the lucrative markets for wearable injectors in the Asia Pacific region. Various factors, such as availability of advanced products, growing awareness regarding wearable injectors, and presence of well-established companies, are expected to boost market growth.
According to World Bank, in 2021, over 30% of the Japanese population was aged 65 & above. The geriatric population is at a higher risk of chronic diseases, which is expected to propel growth of wearable injectors market in this country. In addition, with increasing healthcare spending, wearable injectors market is expected to witness substantial growth in Japan over the forecast period.
Moreover, the increasing prevalence of cancer and lifestyle diseases is likely to boost the wearable injectors market in Japan. For instance, in 2021, 1,024,982 new cancer cases were reported in Japan, and 1,096,955 new cases are estimated to be reported.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan wearable injectors market , including forecasts for subscribers. This country databook contains high-level insights into Japan wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account